A detailed history of Bridgeway Capital Management, LLC transactions in Opti Nose, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 243,100 shares of OPTN stock, worth $102,102. This represents 0.0% of its overall portfolio holdings.

Number of Shares
243,100
Previous 218,100 11.46%
Holding current value
$102,102
Previous $226,000 28.32%
% of portfolio
0.0%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.67 - $1.27 $16,750 - $31,750
25,000 Added 11.46%
243,100 $162,000
Q2 2024

Aug 14, 2024

SELL
$0.82 - $1.44 $98,400 - $172,800
-120,000 Reduced 35.49%
218,100 $226,000
Q3 2023

Nov 14, 2023

SELL
$0.93 - $1.38 $55,707 - $82,662
-59,900 Reduced 15.05%
338,100 $415,000
Q2 2023

Aug 14, 2023

BUY
$1.11 - $2.05 $61,716 - $113,979
55,600 Added 16.24%
398,000 $489,000
Q1 2023

May 15, 2023

BUY
$1.63 - $2.02 $399,350 - $494,900
245,000 Added 251.54%
342,400 $660,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $4.01 $600,250 - $701,750
-175,000 Reduced 64.24%
97,400 $356,000
Q1 2022

May 16, 2022

BUY
$1.77 - $2.93 $159,300 - $263,700
90,000 Added 49.34%
272,400 $673,000
Q4 2021

Feb 14, 2022

SELL
$1.55 - $3.1 $69,750 - $139,500
-45,000 Reduced 19.79%
182,400 $295,000
Q3 2021

Nov 15, 2021

SELL
$2.35 - $3.16 $117,500 - $158,000
-50,000 Reduced 18.02%
227,400 $682,000
Q2 2021

Aug 16, 2021

SELL
$2.91 - $3.83 $116,400 - $153,200
-40,000 Reduced 12.6%
277,400 $863,000
Q1 2021

May 17, 2021

BUY
$3.47 - $4.75 $1.1 Million - $1.51 Million
317,400 New
317,400 $1.17 Million

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $35M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.